|
C13ORF27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.045800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.533600E-02 |
| Normal-vs-Stage2 |
1.403520E-03 |
| Normal-vs-Stage3 |
1.703460E-03 |
| Normal-vs-Stage4 |
2.081500E-02 |
| Stage1-vs-Stage2 |
3.348300E-02 |
| Stage1-vs-Stage3 |
6.427700E-02 |
| Stage1-vs-Stage4 |
2.844200E-01 |
| Stage2-vs-Stage3 |
2.673400E-01 |
| Stage2-vs-Stage4 |
1.915570E-01 |
| Stage3-vs-Stage4 |
6.802400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.658400E-02 |
| Normal-vs-AfricanAmerican |
3.438800E-01 |
| Normal-vs-Asian |
4.659800E-02 |
| Caucasian-vs-AfricanAmerican |
5.527400E-01 |
| Caucasian-vs-Asian |
8.830200E-01 |
| AfricanAmerican-vs-Asian |
5.437400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.878900E-03 |
| Normal-vs-Female |
3.895600E-02 |
| Male-vs-Female |
4.172800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.440400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.843200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.501260E-03 |
| Normal-vs-Age(81-100Yrs) |
4.263200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.721510E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.525900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.644000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.713800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.677600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.464000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.302600E-01 |
| Classical-VS-Follicular |
3.257200E-01 |
| Classical-VS-Other |
1.612230E-01 |
| Classical-VS-Normal |
2.797600E-02 |
| Tall-VS-Follicular |
2.186400E-01 |
| Tall-VS-Other |
3.338600E-01 |
| Tall-VS-Normal |
3.337600E-01 |
| Follicular-VS-Other |
2.265000E-01 |
| Follicular-VS-Normal |
2.048100E-02 |
| Other-VS-Normal |
6.593600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.681400E-03 |
| Normal-vs-N1 |
6.217400E-01 |
| N0-vs-N1 |
4.278100E-02 |
|
|
